Skip to main content

Advertisement

SpringerLink
Log in

Indication for Postoperative Adjuvant Therapy in Biliary Carcinoma Based on Analysis of Recurrence and Survival After Surgical Resection

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Postoperative adjuvant therapy is mandatory for biliary carcinoma because of its unfavorable prognosis. The aim of this study was to evaluate the indication for postoperative adjuvant therapy in biliary carcinoma. The charts of 139 consecutive patients with biliary carcinoma (37 ampullary carcinomas, 36 distal carcinomas, 38 carcinomas of the gallbladder, and 28 hilar cholangiocarcinomas) who underwent surgical resection were retrospectively reviewed. Recurrence rates and survival rates after surgery were analyzed. Of the 139 carcinomas, the recurrence rates of International Union Against Cancer (UICC) stages IA, IB, IIA, IIB, and III cancers were 9%, 20%, 60%, 83%, and 100%, respectively. The recurrence rates of UICC stages II and III cancers were significantly higher than that of UICC stage I cancer (82% vs 13%, P < 0.001). The 5-year survival rates for patients with UICC stages IA, IB, IIA, IIB, and III cancers were 85%, 75%, 36%, 20%, and 0%, respectively. The 5-year survival rates for UICC stages II and III cancers were significantly lower than that for UICC stage I cancer (21% vs 82%, P < 0.001). Postoperative adjuvant therapy should be given to patients with UICC stages II and III biliary carcinomas because of their high rate of recurrence and the poor prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer statistics, 2001. CA Cancer J Clin. 2001;51:15–36.

    Article  PubMed  CAS  Google Scholar 

  2. Okusaka T. Chemotherapy for biliary tract cancer in Japan. Semin Oncol. 2002;29:51–53.

    PubMed  CAS  Google Scholar 

  3. Kim RD, Kundhal PS, McGilvray ID, et al. Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma. J Am Coll Surg. 2006;202:112–119. doi:10.1016/j.jamcollsurg.2005.08.002.

    Article  PubMed  Google Scholar 

  4. Brown KM, Tompkins AJ, Yong S, et al. Pancreaticoduodenectomy is curative in the majority of patients with node-negative ampullary cancer. Arch Surg. 2005;140:529–533. doi:10.1001/archsurg.140.6.529.

    Article  PubMed  Google Scholar 

  5. Duffy JP, Hines OJ, Liu JH, et al. Improved survival for adenocarcinoma of the ampulla of Vater: fifty-five consecutive resections. Arch Surg. 2003;138:941–950. doi:10.1001/archsurg.138.9.941.

    Article  PubMed  Google Scholar 

  6. Allema JH, Reinders ME, van Gulik TM, et al. Results of pancreaticoduodenectomy for ampullary carcinoma and analysis of prognostic factors for survival. Surgery. 1995;117:247–253. doi:10.1016/S0039-6060(05)80197-7.

    Article  PubMed  CAS  Google Scholar 

  7. Murakami Y, Uemura K, Hayashidani Y, et al. Pancreatoduodenectomy for distal cholangiocarcinoma: prognostic impact of lymph node metastasis. World J Surg. 2007;31:337–342. doi:10.1007/s00268-006-0224-0.

    Article  PubMed  Google Scholar 

  8. Sakamoto Y, Kosuge T, Shimada K, et al. Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins. Surgery. 2005;137:396–402. doi:10.1016/j.surg.2004.10.008.

    Article  PubMed  Google Scholar 

  9. Kayahara M, Nagakawa T, Ohta T, et al. Role of nodal involvement and the periductal soft-tissue margin in middle and distal bile duct cancer. Ann Surg. 1999;229:76–83. doi:10.1097/00000658-199901000-00010.

    Article  PubMed  CAS  Google Scholar 

  10. Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996;224:463–475. doi:10.1097/00000658-199610000-00005.

    Article  PubMed  CAS  Google Scholar 

  11. Sasaki R, Itabashi H, Fujita T, et al. Related significance of extensive surgery including resection of the pancreas head for the treatment of gallbladder cancer—from the perspective of mode of lymph node involvement and surgical outcome. World J Surg. 2006;30:36–42. doi:10.1007/s00268-005-0181-z.

    Article  PubMed  Google Scholar 

  12. Yamaguchi R, Nagino M, Oda K, et al. Perineural invasion has a negative impact on survival of patients with gallbladder carcinoma. Br J Surg. 2002;89:1130–1136. doi:10.1046/j.1365-2168.2002.02184.x.

    Article  PubMed  CAS  Google Scholar 

  13. Chijiiwa K, Tanaka M. Carcinoma of the gallbladder: an appraisal of surgical resection. Surgery. 1994;115:751–756.

    PubMed  CAS  Google Scholar 

  14. Rea DJ, Munoz-Juarez M, Farnell MB, et al. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Arch Surg. 2004;139:514–525. doi:10.1001/archsurg.139.5.514.

    Article  PubMed  Google Scholar 

  15. Hemming AW, Reed AI, Fujita S, et al. Surgical management of hilar cholangiocarcinoma. Ann Surg. 2005;241:693–702. doi:10.1097/01.sla.0000160701.38945.82.

    Article  PubMed  Google Scholar 

  16. Nimura Y, Kamiya J, Kondo S, et al. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg. 2000;7:155–162. doi:10.1007/s005340050170.

    Article  PubMed  CAS  Google Scholar 

  17. Miyazaki M, Ito H, Nakagawa K, et al. Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma. J Am Coll Surg. 1999;189:575–583. doi:10.1016/S1072-7515(99)00219-7.

    Article  PubMed  CAS  Google Scholar 

  18. Alberts SR, Al-Khatib H, Mahoney MR, et al. Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial. Cancer. 2005;103:111–118. doi:10.1002/cncr.20753.

    Article  PubMed  CAS  Google Scholar 

  19. Penz M, Kornek GV, Raderer M, et al. Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. Ann Oncol. 2001;12:183–186. doi:10.1023/A:1008352123009.

    Article  PubMed  CAS  Google Scholar 

  20. Ueno H, Okusaka T, Ikeda M, et al. Phase II study of S-1 in patients with advanced biliary tract cancer. Br J Cancer. 2004;91:1769–1774. doi:10.1038/sj.bjc.6602208.

    Article  PubMed  CAS  Google Scholar 

  21. Sobin LH, Wittekind C, eds. International Union Against Cancer (UICC): TNM Classification of Malignant Tumours. 6th ed. New York: Wiley-Liss; 2002.

    Google Scholar 

  22. Japanese Society of Biliary Surgery. General Rules for Surgical and Pathological Studies on Cancer of Biliary Tract. 5th ed. Tokyo: Kanehara; 2003.

    Google Scholar 

  23. Beger HG, Treitschke F, Gansauge F, et al. Tumor of the ampulla of Vater: experience with local or radical resection in 171 consecutively treated patients. Arch Surg. 1999;134:526–532. doi:10.1001/archsurg.134.5.526.

    Article  PubMed  CAS  Google Scholar 

  24. Todoroki T, Koike N, Morishita Y, et al. Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater. Ann Surg Oncol. 2003;10:1176–1183.

    Article  PubMed  Google Scholar 

  25. Todoroki T, Kawamoto T, Koike N, et al. Treatment strategy for patients with middle and lower third bile duct cancer. Br J Surg. 2001;88:364–370. doi:10.1046/j.1365-2168.2001.01685.x.

    Article  PubMed  CAS  Google Scholar 

  26. Suzuki M, Unno M, Oikawa M, et al. Surgical treatment and postoperative outcomes for middle and lower bile duct carcinoma in Japan—experience of a single institute. Hepatogastroenterology. 2000;47:650–657.

    PubMed  CAS  Google Scholar 

  27. Tsukada K, Hatakeyama K, Kurosaki I, et al. Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage. Surgery. 1996;120:816–821. doi:10.1016/S0039-6060(96)80089-4.

    Article  PubMed  CAS  Google Scholar 

  28. Todoroki T, Kawamoto T, Takahashi H, et al. Treatment of gallbladder cancer by radical resection. Br J Surg. 1999;86:622–627. doi:10.1046/j.1365-2168.1999.01085.x.

    Article  PubMed  CAS  Google Scholar 

  29. Todoroki T, Kawamoto T, Koike N, et al. Radical resection of hilar bile duct carcinoma and predictors of survival. Br J Surg. 2000;87:306–313. doi:10.1046/j.1365-2168.2000.01343.x.

    Article  PubMed  CAS  Google Scholar 

  30. Neuhaus P, Jonas S, Bechstein WO, et al. Extended resections for hilar cholangiocarcinoma. Ann Surg. 1999;230:808–819. doi:10.1097/00000658-199912000-00010.

    Article  PubMed  CAS  Google Scholar 

  31. Takada T, Amano H, Yasuda H, et al. Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer. 2002;95:1685–1695. doi:10.1002/cncr.10831.

    Article  PubMed  Google Scholar 

  32. Mehta VK, Fisher GA, Ford JM, et al. Adjuvant chemoradiotherapy for “unfavorable” carcinoma of the ampulla of Vater: preliminary report. Arch Surg. 2001;136:65–69. doi:10.1001/archsurg.136.1.65.

    Article  PubMed  CAS  Google Scholar 

  33. Bosset JF, Mantion G, Gillet M, et al. Primary carcinoma of the gallbladder. Adjuvant postoperative external irradiation. Cancer. 1989;64:1843–1847. doi:10.1002/1097-0142(19891101)64:9<1843::AID-CNCR2820640915>3.0.CO;2-N.

    Article  PubMed  CAS  Google Scholar 

  34. Mahe M, Romestaing P, Talon B, et al. Radiation therapy in extrahepatic bile duct carcinoma. Radiother Oncol. 1991;21:121–127. doi:10.1016/0167-8140(91)90084-T.

    Article  PubMed  CAS  Google Scholar 

  35. Todoroki T, Iwasaki Y, Orii K, et al. Resection combined with intraoperative radiation therapy (IORT) for stage IV (TNM) gallbladder carcinoma. World J Surg. 1991;15:357–366. doi:10.1007/BF01658729.

    Article  PubMed  CAS  Google Scholar 

  36. Serafini FM, Sachs D, Bloomston M, et al. Location, not staging, of cholangiocarcinoma determines the role for adjuvant chemoradiation therapy. Am Surg. 2001;67:839–844.

    PubMed  CAS  Google Scholar 

  37. Metzger J, Sauerbruch T, Ko Y, et al. A phase II trial of gemcitabine in gallbladder and biliary tract carcinomas. Onkologie. 1998;21:232–234. doi:10.1159/000026821.

    Article  Google Scholar 

  38. Scheithauer W. Review of gemcitabine in biliary tract carcinoma. Semin Oncol. 2002;29:40–45.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Division of Clinical Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan

    Yoshiaki Murakami, Kenichiro Uemura, Yasuo Hayasidani, Takeshi Sudo, Yasushi Hashimoto, Hiroki Ohge & Taijiro Sueda

Authors
  1. Yoshiaki Murakami
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenichiro Uemura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yasuo Hayasidani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takeshi Sudo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yasushi Hashimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hiroki Ohge
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Taijiro Sueda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoshiaki Murakami.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murakami, Y., Uemura, K., Hayasidani, Y. et al. Indication for Postoperative Adjuvant Therapy in Biliary Carcinoma Based on Analysis of Recurrence and Survival After Surgical Resection. Dig Dis Sci 54, 1360–1364 (2009). https://doi.org/10.1007/s10620-008-0492-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-008-0492-7

Keywords

Search

Navigation